跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 40,929 条关于
“Cipla Inc.”
全部
40,929
临床试验
11,207
药物
1,601
机构
6,171
资讯
21,950
2个月前
Small Molecule API Market to Reach $370.36 Billion by 2035, Driven by Oncology Demand and Manufacturing Innovation
5个月前
Cipla Receives FDA Approval for Generic Nintedanib Capsules to Treat Idiopathic Pulmonary Fibrosis
上个月
Cipla Secures FDA Approval for First U.S.-Manufactured Generic Advair Diskus Across All Three Strengths
5个月前
Indian Cancer Drug Manufacturers Seek 50% Price Increase as Platinum Costs Surge
去年
ImmunoACT Achieves Profitability with India's First CAR-T Therapy, Treating Over 350 Cancer Patients
2个月前
The Biosimilar Race: APAC's Factory to the World Confronts the Value Trap
去年
Cipla Launches ZEMDRI (Plazomicin) in India to Combat Antimicrobial Resistance
去年
Cipla Receives VAI Status from USFDA for Two Manufacturing Facilities
去年
Formosa Pharmaceuticals and Cipla Form Strategic Partnership for APP13007 Commercialization Across 11 Countries
18天前
Cipla Secures Exclusive Rights to HER2 Bispecific ADC TQB2102 Across Seven Emerging Markets
第 1 页,共 2195 页
上一页
下一页